Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways. [electronic resource]
Producer: 20160628Description: e0142704 p. digitalISSN:- 1932-6203
- Acetylation -- drug effects
- Antineoplastic Agents -- toxicity
- Apoptosis -- drug effects
- Camptothecin -- analogs & derivatives
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- DNA Damage -- drug effects
- Dacarbazine -- analogs & derivatives
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Heterocyclic Compounds, 3-Ring -- pharmacology
- Histone Deacetylase Inhibitors -- toxicity
- Humans
- Hydroxamic Acids -- toxicity
- Irinotecan
- Mitogen-Activated Protein Kinases -- metabolism
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- Reactive Oxygen Species -- metabolism
- STAT3 Transcription Factor -- antagonists & inhibitors
- Sarcoma, Ewing -- metabolism
- Signal Transduction -- drug effects
- Temozolomide
- Tumor Suppressor Protein p53 -- metabolism
- Vorinostat
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.